Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy

BACKGROUND: Despite the survival benefit of implantable-cardioverter-defibrillators (ICDs), the vast majority of patients receiving an ICD for primary prevention do not receive ICD therapy. We sought to assess the role of heterogeneous scar area (HSA) identified by late gadolinium enhancement cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rayatzadeh, Hussein, Tan, Alex, Chan, Raymond H, Patel, Shalin J, Hauser, Thomas H, Ngo, Long, Shaw, Jaime L, Hong, Susie N, Zimetbaum, Peter, Buxton, Alfred E, Josephson, Mark E, Manning, Warren J, Nezafat, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750752/
https://www.ncbi.nlm.nih.gov/pubmed/23574733
http://dx.doi.org/10.1186/1532-429X-15-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750752/
https://www.ncbi.nlm.nih.gov/pubmed/23574733
http://dx.doi.org/10.1186/1532-429X-15-31

Ejemplares similares